Search for: "PFIZER" Results 3061 - 3080 of 4,635
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Jun 2010, 5:22 am by Dr. Shezad Malik
" Still, "Pfizer...has won dismissals of more than 3,000 cases at either the pretrial stage or after the cases have been set for trials. [read post]
24 Jun 2010, 9:19 am by Ted Allen
  A majority of the 70 U.S. companies that have agreed to hold advisory votes have pledged to do so annually, but a few, such as Pfizer and General Mills, have opted for biennial votes, while others, such as Microsoft and Supervalu, plan to hold triennial votes. [read post]
24 Jun 2010, 5:00 am by Kimberly A. Kralowec
During its conference last week (on June 17, 2010), the Supreme Court denied review and depublication in the ninth post-Tobacco II case, Pfizer, Inc. [read post]
23 Jun 2010, 10:28 pm
(Patent Docs) (Patent Docs) Sutent (Sunitinib) - US: Patent infringement complaint following a Para IV certification: Pfizer Inc. et al. v. [read post]
23 Jun 2010, 8:34 am by Dennis Crouch
Pfizer seeks an experienced patent attorney to join its small molecule therapeutics team in Groton, Connecticut. [read post]
22 Jun 2010, 2:12 pm by FDABlog HPM
  Pfizer announced that the company will withdraw the MYLOTARG NDA effective October 15, 2010. [read post]
22 Jun 2010, 12:41 pm by Erin Miller
This edition of “Petitions to Watch” features cases up for consideration at the Justices’ last scheduled private conference of the Term, on Thursday, June 24. [read post]
22 Jun 2010, 12:10 pm by Miller & Zois
Mylotarg, Pfizer’s leukemia drug that was approved by the FDA in 2000 under an accelerated approval program (early approval for drugs that show particular promise) will be pulled from the market. [read post]
22 Jun 2010, 10:10 am
Zambri, founding partner The Wall Street Journal (6/22, Dooren) reports that the FDA has announced that Pfizer Inc. has withdrawn Mylotarg (gemtuzumab ozogamicin) from the US market following research indicating that the medication was not effective and was linked to safety issues. [read post]
22 Jun 2010, 6:00 am by Mark Zamora
Pfizer has agreed to pull a leukemia drug off the market after a follow-up study showed it failed to slow the disease.The Food and Drug Administration cleared the drug Mylotarg in 2000 under its accelerated approval program, which grants speedy access to drugs that show early promise. [read post]
21 Jun 2010, 9:35 pm by Ilya Somin
That’s why I have previously defended the property rights of communists like Bill Ayers and eminent domain abusers such as the Pfizer Corporation. [read post]
21 Jun 2010, 2:30 pm by Lucas A. Ferrara, Esq.
FDA: Pfizer Voluntarily Withdraws Cancer Treatment Mylotarg from U.S. [read post]
21 Jun 2010, 11:46 am by Joe Consumer
  The Court rejected Pfizer’s appeal of a $2.7 million award to Donna Scroggin. [read post]
21 Jun 2010, 9:57 am
They ask as follows: "(i) Are Article 7(2) of [the repealed and re-enacted but regularly cited] Council Directive 89/104 ... to approximate the laws of the Member States relating to trade marks and the associated case-law, in particular the judgments of the Court of Justice in Cases 102/77 Hoffmann-La Roche v Centrafarm and 1/81 Pfizer v Eurim-Pharm and Joined Cases C-427/93, C-429/93 and C-436/93 Bristol-Myers Squibb and Others v Paranova, to be interpreted as meaning that a trade… [read post]
21 Jun 2010, 9:00 am
James Vicini of Reuters reports that "U.S. top court rejects Pfizer punitive damages appeal. [read post]
21 Jun 2010, 7:12 am
The first case to be set for trial is an action brought by Karen Zahn against Pfizer's Wyeth division, which is now back pending before a judge in Galveston, Texas. [read post]
21 Jun 2010, 6:40 am by Miller & Zois
Maybe I should take my donations to the local hospital, instead… Hormone Therapy: Pfizer needs to get ready to try its hormone therapy cases all over the country, now that cases have been sent from Arkansas to their home states (with more awaiting transfer). [read post]
21 Jun 2010, 5:18 am by Mark Zamora
Pfizer is set to defend itself in Texas trial over the company's hormone-replacement drugs after a court overseeing lawsuits over the medicines sent 200 cases back to their home courts.A judge in Galveston, Texas, set a 2011 trial date for Karen Zahn’s claims against Pfizer’s Wyeth unit. [read post]